Quantum-Si (Quantum-Si) FCF Margin % : -5,320.13% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Quantum-Si FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Quantum-Si's Free Cash Flow for the three months ended in Mar. 2024 was $-24.31 Mil. Quantum-Si's Revenue for the three months ended in Mar. 2024 was $0.46 Mil. Therefore, Quantum-Si's FCF Margin % for the quarter that ended in Mar. 2024 was -5,320.13%.

As of today, Quantum-Si's current FCF Yield % is -35.24%.

The historical rank and industry rank for Quantum-Si's FCF Margin % or its related term are showing as below:

QSI' s FCF Margin % Range Over the Past 10 Years
Min: -9178.28 Med: -9178.28 Max: -7117.74
Current: -7117.74

During the past 5 years, the highest FCF Margin % of Quantum-Si was -7117.74%. The lowest was -9178.28%. And the median was -9178.28%.

QSI's FCF Margin % is ranked worse than
90.15% of 1046 companies
in the Biotechnology industry
Industry Median: -145.305 vs QSI: -7117.74

Quantum-Si FCF Margin % Historical Data

The historical data trend for Quantum-Si's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum-Si FCF Margin % Chart

Quantum-Si Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-9,178.28

Quantum-Si Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial												-12,661.02	-11,573.66	-10,234.08	-5,150.50	-5,320.13

Competitive Comparison of Quantum-Si's FCF Margin %

For the Biotechnology subindustry, Quantum-Si's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quantum-Si's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum-Si's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Quantum-Si's FCF Margin % falls into.

Quantum-Si FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Quantum-Si's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-99.309	/	1.082
	=	-9,178.28 %

Quantum-Si's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-24.313	/	0.457
	=	-5,320.13 %

Quantum-Si FCF Margin % Related Terms

Thank you for viewing the detailed overview of Quantum-Si's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum-Si (Quantum-Si) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum-Si Inc (NAS:QSI) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

530 Old Whitfield Street, Guilford, CT, USA

Website

https://www.quantum-si.com

Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.

Executives

Amir Jafri	director	C/O QUANTUM-SI INCORPORATED, 29 BUSINESS PARK DR., BRANFORD CT 06405
John P. Kenny	director	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Jeffry R. Keyes	officer: Chief Financial Officer	13950 STOWE DRIVE, POWAY CA 92064-8803
Scott Mendel	director	5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008
Christian Lapointe	officer: General Counsel & Corp. Secr.	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Grace Johnston	officer: Chief Commercial Officer	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Kevin Rakin	director, officer: Chairman and CEO	36 CHURCH LANE, WESTPORT CT 06880
Jeffrey Alan Hawkins	director, officer: Chief Executive Officer	5964 LA PLACE COURT, CARLSBAD CA 92008
Vikram Bajaj	director	600 MONTGOMERY STREET, SUITE 4500, SAN FRANCISCO CA 94111
Jonathan M Rothberg	director, 10 percent owner	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Matthew Dyer	officer: Chief Business Officer	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Michael P Mckenna	officer: President and COO	C/O CURAGEN CORP, 555 LONG WHARF DR. 11TH FL., NEW HAVEN CT 06511
Patrick Schneider	officer: President and COO	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
John Viii Stark	director, officer: Chief Executive Officer	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
2012 Jmr Trust Common Llc	10 percent owner	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437